A phase II study of doxifluridine in patients with advanced breast cancer.
Alberto
P
P
Division d'Onco-Hématologie, Hôpital Cantonal Universitaire, Geneva, Switzerland.
Jungi
W F
WF
Siegenthaler
P
P
Mermillod
B
B
Obrecht
J P
JP
Decoster
G
G
Cavalli
F
F
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D005467:Floxuridine / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged
D000970:Antineoplastic Agents; D005467:Floxuridine; C025034:doxifluridine